How much does factor VII cost?
The base case cost per dose of rFVIIa is $6,408. rFVIIa remains the dominant strategy unless the cost per dose exceeds $7,500. At higher costs per dose, the mCER remains less than $50,000/QALY until the cost per dose surpasses $14,500.
How much does factor 9 cost?
The per patient cost for this drug was $366,496 in 2014. This Coagulation Factor IX drug is used to control and prevent bleeding in patients with hemophilia B. The cost per patient in 2014 was $302,364.
When do you use recombinant factor VIIa?
In the United States, the FDA-approved indications for recombinant factor VIIa is for bypassing inhibitors to factors VIII and IX in patients with hemophilia A and B respectively and for treatment of congenital factor VII deficiency.
What is the difference between NovoSeven and NovoSeven RT?
The new NovoSeven RT provides the same safety and efficacy as the original NovoSeven(R)-but it can be transported and administered quickly.” NovoSeven RT has been manufactured to be room temperature stable (from 36 degrees F to 77 degrees F outside a refrigerator).
How much does Novoseven cost?
The cost for NovoSeven RT intravenous powder for injection (1000 mcg (1 mg)) is around $2,602 for a supply of 1000 powder for injection, depending on the pharmacy you visit….Intravenous Powder For Injection.
Quantity | Per unit | Price |
---|---|---|
5000 | $2.59 | $12,972.50 |
Is hemophilia treatment expensive?
Treatment for hemophilia is extremely expensive. This is a lifetime expense. The average cost is $40,000 to $50,000 a year. Complications from hemophilia can bring further expenses, which may be over $100,000.
How much does NovoSeven cost?
How long does NovoSeven last?
After reconstitution, NovoSeven (coagulation factor viia (recombinant)) may be stored either at room temperature or refrigerated for up to 3 hours.
What is NovoSeven made from?
NovoSeven is a novel product and contains activated recombinant DNA human coagulation factor VII (rFVIIa). The recombinant molecule is produced in baby hamster kidney (BHK) cells. Recombinant FVIIa is almost identical to human plasma FVIIa except for a difference in glycosylation.
What is the cost of factor VIII?
In that year, the price of factor VIII averaged 2.53 U.S. dollars in the United States. Factor VIII is a drug used, for example, to treat patients with hemophilia A….Average prices of factor VIII in selected countries in 2017 (in U.S. dollars)*
Characteristic | Average price in U.S. dollars |
---|---|
United States | 2.53 |
How much does replacement therapy for hemophilia cost?
Hemophilia B: Cause and current treatment Current therapy involves infusions with clotting-factor replacement therapy in different formulations to prevent or treat bleeding. Depending on the formulation, factor replacement ranges from about $300,000 to $776,000 annually.